Although there was heterogeneity among studies, such as differences in TSPO radioligands and outcome measurement methods, which led to different results, a recent meta-analysis suggested that TSPO tracers were elevated in the gray matter of patients with schizophrenia when the binding potential was used as the outcome measure, rather than the volume of distribution [8, 9]. Here, TSPO is linked to schizophrenia.